Inventor · disambiguated record
Lidia Mosyak
Also filed as: MOSYAK LIDIA
16 granted patents·13 pending applications·60 citations·filing 2002–2024
90Inventor score
Files withPFIZER15WYETH CORP4KODIAK SCIENCES INC3RINAT NEUROSCIENCE CORP2BETH ISRAEL DEACONESS MEDICAL CT INC1
Top patents by PatentIndex Score
29 records- 0193US9840553B2Dual PDGF/VEGF antagonistsKODIAK SCIENCES INC·Filed 2015·Granted Dec 12, 2017·18 cites·34 claims
- 0292US11155610B2Dual PDGF/VEGF antagonistsKODIAK SCIENCES INC·Filed 2017·Granted Oct 26, 2021·7 cites·22 claims
- 0391US11059876B2IL-15 variants and uses thereofPFIZER·Filed 2019·Granted Jul 13, 2021·7 cites·36 claims
- 0485US7693698B2Method for identifying or designing a candidate agent that interacts with LINGO-1 polypeptide using a LINGO-1 three-dimensional structureWYETH LLC·Filed 2007·Granted Apr 6, 2010·14 cites·29 claims
- 0582US9884921B2Bispecific heterodimeric diabodies and uses thereofPFIZER·Filed 2015·Granted Feb 6, 2018·4 cites·34 claims
- 0681US10829553B2Interferon beta antibodies and uses thereofPFIZER·Filed 2017·Granted Nov 10, 2020·2 cites·17 claims
- 0781US9248189B2Anti-glucagon receptor antibodies and pharmaceutical compositions thereofRINAT NEUROSCIENCE CORP·Filed 2014·Granted Feb 2, 2016·5 cites·14 claims
- 0878US12448439B2Interferon beta antibodies and uses thereofPFIZER·Filed 2023·Granted Oct 21, 2025·0 cites·9 claims
- 0969US7167802B2Methods for identifying agents that interact with MAP kinase activated protein kinase 2WYETH CORP·Filed 2002·Granted Jan 23, 2007·3 cites·18 claims
- 1068US12269896B2Antibodies specific for GUCY2c and uses thereofPFIZER·Filed 2022·Granted Apr 8, 2025·0 cites·12 claims
- 1165US11858986B2Interferon beta antibodies and uses thereofPFIZER·Filed 2020·Granted Jan 2, 2024·0 cites·18 claims
- 1263US2025154287A1ANTI-MIGIS-alpha ANTIBODIES AND METHODS OF USE THEREOFPFIZER·Filed 2024·Application pending·0 cites
- 1362US2020262905A1Dual pdgf/vegf antagonistsKODIAK SCIENCES INC·Filed 2020·Application pending·0 cites
- 1462US2021324028A1IL-15 Variants and Uses ThereofPFIZER·Filed 2021·Application pending·0 cites
- 1561US2024010696A1IL-12 Variants and Uses ThereofPFIZER·Filed 2023·Application pending·0 cites
- 1661US2025163168A1Novel antibodies and antibody conjugates for the treatment of metabolic disordersPFIZER·Filed 2024·Application pending·0 cites
- 1757US11525010B2Antibodies specific for GUCY2c and uses thereofPFIZER·Filed 2019·Granted Dec 13, 2022·0 cites·24 claims
- 1857US2024083991A1Anti-bmp9 antibodies and methods of use thereofPFIZER·Filed 2023·Application pending·0 cites
- 1956US2023365701A1Anti-lymphotoxin beta receptor antibodies and methods of use thereofPFIZER·Filed 2023·Application pending·0 cites
- 2048US2024209061A1Fusion proteins and uses thereofPFIZER·Filed 2021·Application pending·0 cites
- 2147US12371507B2CDCP1 antibodies and antibody drug conjugatesBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Granted Jul 29, 2025·0 cites·8 claims
- 2247US2007100560A1Crystal structures of MK2 and uses thereofWYETH A DELAWARE CORP·Filed 2006·Application pending·0 cites
- 2347US2018155452A1Bispecific heterodimeric diabodies and uses thereofPFIZER·Filed 2017·Application pending·0 cites
- 2441US7615363B2Aggrecanase structureWYETH CORP·Filed 2006·Granted Nov 10, 2009·0 cites·36 claims
- 2541US2016311912A1Anti-glucagon receptor antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2015·Application pending·0 cites
- 2640US7555415B2Methods for the design of estrogen receptor ligandsWYETH CORP·Filed 2006·Granted Jun 30, 2009·0 cites·28 claims
- 2739US2004091908A1Crystal structures of Kv channel proteins and uses thereofFiled 2003·Application pending·0 cites
- 2836US7584087B2Structure of protein kinase C thetaWYETH CORP·Filed 2005·Granted Sep 1, 2009·0 cites·25 claims
- 2936US2007048785A1Anti-IL-13 antibodies and complexesLIN LAURA L·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lidia Mosyak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →